433 related articles for article (PubMed ID: 25483535)
21. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008.
Tsou TP; Liu CC; Huang JJ; Tsai KJ; Chang HF
Vaccine; 2011 Apr; 29(16):2956-61. PubMed ID: 21329774
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis A in Poland in 2012.
Baumann-Popczyk A
Przegl Epidemiol; 2014; 68(2):253-6, 361-2. PubMed ID: 25135510
[TBL] [Abstract][Full Text] [Related]
24. [Hepatitis A in Poland in 2009].
Baumann-Popczyk A
Przegl Epidemiol; 2011; 65(2):255-8. PubMed ID: 21913470
[TBL] [Abstract][Full Text] [Related]
25. Incidence of Hepatitis A in Argentina after vaccination.
Vacchino MN
J Viral Hepat; 2008 Oct; 15 Suppl 2():47-50. PubMed ID: 18837834
[TBL] [Abstract][Full Text] [Related]
26. Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
Thompson C; Dey A; Fearnley E; Polkinghorne B; Beard F
Vaccine; 2017 Jan; 35(1):170-176. PubMed ID: 27876203
[TBL] [Abstract][Full Text] [Related]
27. Incidence of hepatitis A in Israel following universal immunization of toddlers.
Dagan R; Leventhal A; Anis E; Slater P; Ashur Y; Shouval D
JAMA; 2005 Jul; 294(2):202-10. PubMed ID: 16014594
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
[TBL] [Abstract][Full Text] [Related]
29. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
30. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience.
Germinario C; Lopalco PL; Chirona M; Da Villa G
Vaccine; 2000 Feb; 18 Suppl 1():S83-5. PubMed ID: 10683558
[TBL] [Abstract][Full Text] [Related]
31. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
Estripeaut D; Contreras R; Tinajeros O; Castrejón MM; Shafi F; Ortega-Barria E; DeAntonio R
Vaccine; 2015 Jun; 33(28):3200-7. PubMed ID: 25981490
[TBL] [Abstract][Full Text] [Related]
32. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
33. [Hepatitis A in Poland in the years 2006-2007].
Baumann A
Przegl Epidemiol; 2009; 63(2):241-4. PubMed ID: 19799253
[TBL] [Abstract][Full Text] [Related]
34. [Study of a population outbreak of hepatitis A. Effectiveness of vaccination as a control measure].
Díaz Villaescusa MJ; Almar Marqués E; Gómez Martínez A; Mateos Ramos A; Segura Cebollada P; de la Cruz de Julián I; Navarro Honrubia C; Ramírez Córcoles C
Gac Sanit; 2010; 24(4):329-33. PubMed ID: 20483510
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of hepatitis A vaccination as post-exposure prophylaxis.
Parrón I; Planas C; Godoy P; Manzanares-Laya S; Martínez A; Sala MR; Minguell S; Torner N; Jané M; Domínguez A;
Hum Vaccin Immunother; 2017 Feb; 13(2):423-427. PubMed ID: 27925847
[TBL] [Abstract][Full Text] [Related]
36. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel.
Chodick G; Green MS; Heymann AD; Rosenmann L; Shalev V
Prev Med; 2007 Nov; 45(5):386-91. PubMed ID: 17599401
[TBL] [Abstract][Full Text] [Related]
37. Incidence of hepatitis A in the United States in the era of vaccination.
Wasley A; Samandari T; Bell BP
JAMA; 2005 Jul; 294(2):194-201. PubMed ID: 16014593
[TBL] [Abstract][Full Text] [Related]
38. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A].
Zhao Y; Meng Z; Guo J; Wang X; Duo C; Liu H; Yao J; Chai S; Zhu H; Xu Z
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis A in Australia in the 1990s: future directions in surveillance and control.
Amin J; Heath T; Morrell S
Commun Dis Intell; 1999 May; 23(5):113-20. PubMed ID: 10429311
[TBL] [Abstract][Full Text] [Related]
40. [Hepatitis A in Poland in 2008].
Baumann A
Przegl Epidemiol; 2010; 64(2):235-7. PubMed ID: 20731228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
